Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

vascular endothelial growth factor-antisense oligonucleotide

(VAS-kyoo-ler EN-doh-THEE-lee-ul grothe FAK-ter-AN-tee-sents AH-lih-goh-NOO-klee-oh-tide)
A substance that has been studied in the treatment of cancer. It binds to the RNA for a protein called vascular endothelial growth factor (VEGF) that stimulates the growth of new blood vessels. Vascular endothelial growth factor-antisense oligonucleotide blocks the cell’s ability to make VEGF, which may kill tumors that need new blood vessels to grow. It is a type of antisense oligonucleotide and a type of gene expression inhibitor. Also called VEGF-AS.
Search NCI's Dictionary of Cancer Terms